Discovery of dipeptidyl peptidase IV (DPP-IV) inhibitors by structure-based de novo design

被引：0

作者：

Qiao, L ^{[1
]}

Baumann, C ^{[1
]}

Crysler, C ^{[1
]}

Ninan, N ^{[1
]}

Abad, M ^{[1
]}

Spurlino, J ^{[1
]}

DesJarlais, R ^{[1
]}

Kervinen, J ^{[1
]}

Neeper, M ^{[1
]}

Bayoumy, S ^{[1
]}

Williams, R ^{[1
]}

Deckman, I ^{[1
]}

Tomczuk, B ^{[1
]}

Moriarty, K ^{[1
]}

机构：

[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Exton, PA 19341 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 229卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

205-MEDI

引用

页码：U145 / U145

页数：1

共 50 条

[1] Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors
Lam, Betty
Zhang, Zhiyuan
Stafford, Jeffery A.
Skene, Robert J.
Shi, Lihong
Gwaltney, Stephen L., II
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (21) : 6628 - 6631
[2] Do Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Cause Heart Failure?
Clifton, Peter
[J]. CLINICAL THERAPEUTICS, 2014, 36 (12) : 2072 - 2079
[3] Synthetic and phytocompounds based dipeptidyl peptidase-IV (DPP-IV) inhibitors for therapeutics of diabetes
Singh, Anand-Krishna
Jatwa, Rameshwar
Purohit, Ashok
Ram, Heera
[J]. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2017, 19 (10) : 1036 - 1045
[4] Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin
Taldone, Tony
Zito, S. William
Talele, Tanaji T.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (02) : 479 - 484
[5] Inhibition of dipeptidyl peptidase IV (DPP-IV) by tryptophan containing dipeptides
Nongonierma, Alice B.
FitzGerald, Richard J.
[J]. FOOD & FUNCTION, 2013, 4 (12) : 1843 - 1849
[6] Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV)
Ferraris, Dana
Belyakov, Sergei
Li, Weixing
Oliver, Eddie
Ko, Yao-Sen
Calvin, David
Lautar, Susan
Thomas, Bert
Rojas, Camilo
[J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (06) : 597 - 608
[7] Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors
Wallace, Michael B.
Feng, Jun
Zhang, Zhiyuan
Skene, Robert J.
Shi, Lihong
Caster, Christopher L.
Kassel, Daniel B.
Xu, Rongda
Gwaltney, Stephen L., II
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (07) : 2362 - 2367
[8] De Novo Design of High Potent DPP-IV Inhibitors Based on the Scaffold of Cyanopyrrolidine
Jiang, Yu-Lei
Yuan, Hao-Liang
Zhang, Wei-Wei
Liu, Hai-Chun
Zhang, Yan-Min
Xiong, Xiao
Xu, Jin-Xing
Lu, Shuai
Lu, Tao
Chen, Ya-Dong
[J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2015, 12 (06) : 479 - 487
[9] Docking Study of Novel Pyrrolidine Derivatives as Potential Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors
Verma, Sant Kumar
Sharma, Shashi Kant
Thareja, Suresh
[J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2015, 12 (04) : 284 - 291
[10] Topical administration of dipeptidyl peptidase IV (DPP-IV) inhibitors prevents retinal neurodegeneration in experimental diabetes
Hernandez, Cristina
Bogdanov, Patricia
Sola-Adell, Cristina
Sampedro, Joel
Valeri, Marta
Simo-Servat, Olga
Herance, Raul
Simo, Rafael
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)

← 1 2 3 4 5 →